Neoadjuvant Pembrolizumab and Chemotherapy in Resectable Esophageal Cancer: An Open-Label, Single-Arm Study (PEN-ICE)

Hongtao Duan, Changjian Shao, Minghong Pan, Honggang Liu, Xiaoping Dong, Yong Zhang, Liping Tong, Yingtong Feng, Yuanyuan Wang, Lu Wang, Neil B. Newman, Inderpal S. Sarkaria, John V. Reynolds, Francesco De Cobelli, Zhiqiang Ma, Tao Jiang, Xiaolong Yan

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'Neoadjuvant Pembrolizumab and Chemotherapy in Resectable Esophageal Cancer: An Open-Label, Single-Arm Study (PEN-ICE)'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science